28 related articles for article (PubMed ID: 15788130)
1. HAG (Homoharringtonine, Cytarabine, G-CSF) Regimen for the Treatment of Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Meta-Analysis with 2,314 Participants.
Xie M; Jiang Q; Li L; Zhu J; Zhu L; Zhou D; Zheng Y; Yang X; Zhu M; Sun J; Xie W; Ye X
PLoS One; 2016; 11(10):e0164238. PubMed ID: 27706258
[TBL] [Abstract][Full Text] [Related]
2. [Isoharringtonine induces apoptosis in human leukemia HL-60 cell].
Shi B; Han R
Yao Xue Xue Bao; 1998 Jun; 33(6):407-12. PubMed ID: 12016908
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
Zhang GS; Liu DS; Dai CW; Li RJ
Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520
[TBL] [Abstract][Full Text] [Related]
4. Betanin a betacyanin pigment purified from fruits of Opuntia ficus-indica induces apoptosis in human chronic myeloid leukemia Cell line-K562.
Sreekanth D; Arunasree MK; Roy KR; Chandramohan Reddy T; Reddy GV; Reddanna P
Phytomedicine; 2007 Nov; 14(11):739-46. PubMed ID: 17482444
[TBL] [Abstract][Full Text] [Related]
5. [Two-dimensional polyacrylamide gel electrophoresis analysis of apoptosis in K562 cells induced by harringtonine].
Li R; Liu XL; Du QF; Zhang S; Zhou SY
Ai Zheng; 2004 Oct; 23(10):1155-60. PubMed ID: 15473926
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms in C-Phycocyanin induced apoptosis in human chronic myeloid leukemia cell line-K562.
Subhashini J; Mahipal SV; Reddy MC; Mallikarjuna Reddy M; Rachamallu A; Reddanna P
Biochem Pharmacol; 2004 Aug; 68(3):453-62. PubMed ID: 15242812
[TBL] [Abstract][Full Text] [Related]
7. Induction of apoptosis by homoharringtonine in G1 phase human chronic myeloid leukemic cells.
Mai WY; Lin MF
Chin Med J (Engl); 2005 Mar; 118(6):487-92. PubMed ID: 15788130
[TBL] [Abstract][Full Text] [Related]
8. Homoharringtonine for the treatment of chronic myelogenous leukemia.
Quintás-Cardama A; Cortes J
Expert Opin Pharmacother; 2008 Apr; 9(6):1029-37. PubMed ID: 18377344
[TBL] [Abstract][Full Text] [Related]
9. Homoharringtonine: a new treatment option for myeloid leukemia.
Luo CY; Tang JY; Wang YP
Hematology; 2004 Aug; 9(4):259-70. PubMed ID: 15621733
[TBL] [Abstract][Full Text] [Related]
10. [Research Progress of Homoharringtonine Effect on IM-resistant Chronic Myelogenous Leukemia -Review].
Wang Q; Li YF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):596-599. PubMed ID: 28446318
[TBL] [Abstract][Full Text] [Related]
11. Homoharringtonine: an effective new natural product in cancer chemotherapy.
Zhou DC; Zittoun R; Marie JP
Bull Cancer; 1995 Dec; 82(12):987-95. PubMed ID: 8745664
[TBL] [Abstract][Full Text] [Related]
12. Homoharringtonine and omacetaxine for myeloid hematological malignancies.
Lü S; Wang J
J Hematol Oncol; 2014 Jan; 7():2. PubMed ID: 24387717
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
